Skip to content
An Initiative of AVAC In partnership with Access Bridge
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 1 - 10 of 433

Selected Filters:
9 November 2026

Advancing Access to LEN for PrEP in Kenya, Malawi, and Uganda

Since its launch in December 2025, LEN for PrEP has been introduced in 10 African countries. Countries put in place plans to introduce LEN quickly. To support the rapid introduction of LEN in three early adopter countries, Lvcthealth in Kenya, Pakachere Institute of Health and Development Communication (Pakachere) in Malawi, and HEPS-Uganda collaborated with Ministries…

Service Delivery

Event
14 October 2026

PrEP Power Demand Generation Toolkit

The PrEP Power demand generation toolkit is intended for use by local partners working with key populations (KP): men who have sex with men, trans and gender diverse people, sex workers, and people who use drugs. The PrEP Power project ran human-centered design (HCD) workshops with community members in Eswatini, Kenya, and Zambia. Everything in…

Demand Creation/Marketing, Research, Service Delivery

Document
7 August 2026

Accelerating Policy Approval and Uptake of the Dual Prevention Pill in Zambia through Early Stakeholder Engagement

This article from AIDS Care discusses how early, multistakeholder engagement is accelerating early approval and rollout of the Dual Prevention Pill in Zambia, and how these lessons can be applied in other contexts.

Community/Advocacy

External Link
10 July 2026

Nigeria National HIV Prevention Plan 2026–2030

This plan, developed by Nigeria’s Federal Ministry of Health and Social Welfare and National Agency for the Control of AIDS, provides a roadmap for reversing the HIV epidemic in Nigeria.

Normative Guidance/Policies

Document
10 July 2026

Ghana National HIV Prevention Roadmap, 2026-2028

This National HIV Prevention Roadmap 2026-2028 outlines Ghana’s HIV and AIDS prevention measures which are based on the five core prevention pillars -Adolescent Girls and Young Women, Adolescent Boys and Young Men, Vulnerable Populations, Condoms, and Anti-Retroviral based Prevention.

Normative Guidance/Policies

Document
10 July 2026

Implementation Guide for Clinicians on the Delivery of Long-Acting Injectable Pre-Exposure Prophylaxis in Zimbabwe, 2026

These clinical guidelines, developed by Zimbabwe’s Ministry of Health and Child Care in 2026, can be used to support delivery of injectable lenacapavir (LEN) and cabotegravir (CAB).

Normative Guidance/Policies

Document
10 July 2026

Mozambique Guidelines for Combined Biomedical Prevention of HIV, STIs, and Viral Hepatitis, 2025

These clinical guidelines, developed by Mozambique’s Ministry of Health in 2025, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR).

Normative Guidance/Policies

Document
10 July 2026

Lesotho Addendum to HIV Prevention, Treatment, and Care Guidelines, 2026

These clinical guidelines, developed by Lesotho’s Ministry of Health in 2026, can be used to support delivery of both PrEP and PEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR).

Normative Guidance/Policies

Document
10 July 2026

Introduction and Scale‑up of the Dapivirine Vaginal Ring, Long‑Acting Injectable Cabotegravir and Lenacapavir for HIV Prevention in Eswatini Implementation Plan Version II, 2025-2030

This PrEP Implementation Plan, developed by Eswatini’s Ministry of Health, is a strategic roadmap to guide Eswatini’s scale-up of HIV prevention. It translates global WHO guidance and national commitments into actionable steps, ensuring that oral PrEP, the dapivirine vaginal ring, and long-acting injectables such as cabotegravir and lenacapavir are introduced in a coordinated, evidence-based way.…

Normative Guidance/Policies

Document
10 July 2026

Eswatini Pre-Exposure Prophylaxis Implementation Guidelines, 2025

These implementation guidelines, developed by Eswatini’s Ministry of Health in 2025, can be used to support delivery of PrEP, including newer, long-acting options such as injectable lenacapavir (LEN), cabotegravir (CAB), and the dapivirine vaginal ring (DVR).

Normative Guidance/Policies

Document